Date:2/23/2011

of government regulation of the drug,  medical device and biotechnology industry; consolidation within the pharmaceutical industry and competition within the biopharmaceutical services industry; the potential for significant liability to clients and third parties; the potential adverse impact of health care reform; and the effects of exchange rate fluctuations and other international economic, political, and other risks.   Such factors and others are discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the quarter ended December 31, 2010 as filed with the SEC on February 9, 2011, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequent to the date of this press release.

PAREXEL is a registered trademark of PAREXEL International Corporation, and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of PAREXEL International Corporation, Perceptive Informatics, Inc. or their respective owners and are hereby acknowledged.ContactsJennifer Baird, Senior Director of Public Relations

Gene Carozza/Kim BakerPAREXEL International

PAN CommunicationsTel: +781-434-4409

Tel: +978-474-1900Email: Jennifer.Baird@PAREXEL.com

Email: PAREXEL@pancomm.com
'/>"/>

SOURCE PAREXEL International Corporation Copyright©2010 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine technology :

1. Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
2. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
3. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
4. Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials
5. Perceptive Informatics Introduces Greater Convergence Between EDC and RTSM Solutions in Its eClinical Suite
6. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
7. FUJIFILM Establishes Medical Informatics Organization
8. BioInformatics, LLC New Report - The Market Outlook for Research Products in FY2010
9. Aditi Technologies Join Hands With Microsoft BioIT Alliance to Offer Solutions in Bioinformatics Space
10. Duke Medicine to Train Healthcare Professionals in Health Informatics
11. Ambry Genetics and SoftGenetics Form Exclusive Alliance for Extended Bioinformatics Support for Next Generation Sequencing Projects